Chairman of the Board
ViveckGoenka
Sr.Vice President-BPD
Neil Viegas
Vice President-BPD
Harit Mohanty
Editor Viveka Roychowdhury*
Editorial Team
Lakshmipriya Nair
Kalyani Sharma
Kavita Jani
Neha Aathavale
DESIGN
Art Director
Pravin Temble
Senior Designer
Rekha Bisht
Senior Artist
Rakesh Sharma
Marketing Team
Rajesh Bhatkal
Douglas Menezes
Ashish Rampure
Debnarayan Dutta
Production Co-ordinator
DhananjayNidre
Scheduling & Coordination
Pushkar Waralikar
CIRCULATION
Mohan Varadkar
P0: 14 DR BILALTHANGALTM Medical Lead, NURA
21 CORPORATE WELLNESS REVOLUTION: AXONCARE POISED TO BECOME THE FIRSTCHOICE
22 SYSMEX STRENGTHENS ITS DIRECT OPERATIONS IN INDIA
23 MONSOON HEALTH WATCH: STAYSAFE, STAYHEALTHY!
25 THE BUDGET PROMISE: NEXT LEAPTOWARDS VIKSITBHARAT
27 GLOBAL COLLABORATION SPURS BREAKTHROUGHS IN INTERVENTIONAL CARDIOLOGYAT IJCTO 2024
Regd.With RNI No.MAHENG/2007/22045.Postal Regd.No.MCS/162/2022 - 24.Printed and Published byVaidehi Thakar on behalf of The Indian Express (P) Limited and Printed at The Indian Express Press,Plot No.EL-208,TTC Industrial Area,Mahape,Navi Mumbai-400710 and Published at Mafatlal Centre,7th floor,Ramnath Goenka Marg,Nariman Point,Mumbai 400021.
Editor: Viveka Roychowdhury.* (Editorial & Administrative Offices: Mafatlal Centre,7th floor,Ramnath Goenka Marg,Nariman Point,Mumbai 400021) * Responsible for selection of news under the PRB Act.Copyright © 2017.The Indian Express (P) Ltd.All rights reserved throughout the world. Reproduction in anymanner,electronic or otherwise,in whole or in part,without prior written permission is prohibited.
The Union Budget 2024-25 turned out to be a damp squib for the healthcare sector. Barring the cut of customs duties on three cancer medications (experts argued that even with these cuts these medications would still be very expensive) and a reduction of Basic Customs Duty (BCD) on specific X-ray related products, experts were disappointed that there was no concerted impetus for healthcare infrastructure or the manufacturing of medical devices.
The Union Health Ministry's allocation of Rs 90,658.63 crore in the interim Budget for 2024-2025, does represent a 12.59 per cent increase from the revised estimate of Rs 80,517.62 crore in the 2023-2024 Budget. The lower than expected allocation is most probably due to the under utilisation of previously allocated funds. For instance, the ministry had been allocated Rs 6500 crores last year (Budget Estimates 2023-2024) but could utilise only Rs 1519.87 crore (Revised Estimates 2023-2024). Thus BE 2024-2025 are considerably low at Rs 1274.79 crore.
However this is not the case with the flagship Ayushman Bharat - Pradhan Mantri Jan Arogya Yojana (PMJAY). BE 2023-2024 were Rs 7200.00 crore, RE 2023-2024 was lower at Rs 6800 crore indicating some shortfall in utilisation. However BE 2024-2025 is Rs 7300 crore, perhaps indicating a commitment to this cause. But PMJAY performance audits point to a sad reality.
Industry experts point to a lot of leakages flagged by the Comptroller and Auditor General of India (CAG) in a report on the PMJAY, tabled in Parliament last August. The report highlighted discrepancies under five major heads: Beneficiary Identification and Registration, Hospital Empanelment and Management, Claims Management, Financial Management, and lastly Monitoring and Grievance Redressal.
The CAG report points out that in the absence of adequate validation controls, errors were noticed in beneficiary database i.e. invalid names, unrealistic date of birth, duplicate PMJAY IDs, unrealistic size of family members in a household etc. Ineligible households were found registered as PMJAY beneficiaries and had availed the benefits ranging between Rs 0.12 lakh to Rs 22.44 crore under the Scheme.
The CAG recommendations ranged from the Ministry and States/UTs putting a suitable mechanism for identifying state-wise beneficiaries under the scheme and to weed out ineligible beneficiaries in a time-bound manner. The registration process needs to be strengthened to avoid delay in registration beyond the prescribed time. Validation checks should be in place so as to avoid invalid entries and increase the accuracy and reliability of the data.
The CAG report also highlighted that some of the empanelled health care providers (EHCPs) neither fulfilled minimum criteria of support system and infrastructure nor conformed to the quality standards
PMJAY performance audits highlight discrepancies that need to be plugged to make the scheme more efficient
and criteria prescribed under the Scheme guidelines. Beneficiaries in some states were charged for their treatment in empanelled EHCPs resulting in increase in out-of-pocket expenditure of beneficiaries.
On this the CAG emphasised the strong need to invest in public hospitals to improve and upgrade the quality of the existing health facilities. More private hospitals could be encouraged to join under the Scheme in all the Districts in order to build an effective and accountable network of health service providers as per quality standard.
Importantly, the CAG stressed the monitoring of EHCPs through physical inspections and necessary audits so that mal-practices may get detected and action may be initiated against the errant EHCPs. The National Health Authority (NHA) and State Health Authorities (SHAs) should also have a mechanism to monitor and curb instances involving out of pocket expenditure by the beneficiaries.
While urging that processing and payment of the claims must be done on time after ensuring necessary scrutiny by SHAs, the CAG pointed out that they must ensure that claim amount is utilised by Public/Government Hospitals for improving the overall infrastructure, functioning of the hospital, quality of services and delivery of services and for incentives to staff.
Under the Financial Management head, the CAG recommended that the NHA should exercise due diligence while releasing the grant to SHAs to ensure fulfilment of corresponding State commitments, actual expenditure against past releases and also avoid idling of funds. Diversion of grant from one head to another should be discouraged and NHA/SHA should ensure that grant is utilised for the purpose it was released.
The CAG also urged that the amount due from insurance companies and interest from SHAs may be recovered at the earliest. NHA must put in a mechanism to map and identify PMJAY beneficiaries so that there is no overlap of PMJAY and state specific schemes. In terms of monitoring and grievance redressal, the CAG report recommended that anti-fraud activities must be taken-up on urgent basis and defaulters should be penalised in a timely manner.
A more recent Public Accounts Committee (PAC) PMJAY performance audit, also followed up on the recommendations of the CAG 2023 report. While speedier registrations was one, the PAC also recommended the formation of an independent body to oversee the updating of PMJAY coverage, and validation of the database. The hope is these leaks are soon plugged so that the increased allocation will be more effective used and reach the most deserving beneficiaries.
VIVEKA ROYCHOWDHURY, Editor viveka.r@expressindia.com
viveka.roy3@gmail.com
Ramaiah Memorial Hospital (RMH) has signed an exclusive agreement with the New York-based Mount Sinai Health (MSH) System.This partnership aims at advancing healthcare services through collaborations in clinical excellence,quality of care,research, innovation and technology. Dr Samin Sharma ,Director of Interventional Cardiology and Clinical Cardiology,MSH and Dr VKBahl ,Interventional Cardiologist,RMH in an interaction with Neha Aathavale share more details on the same
Can you elaborate on the strategic vision behind this partnership?
Dr Sharma: Ramaiah Memorial Hospital is a large organisation that has been serving a broad range of patients in Bangalore, focusing particularly on those from lower economic backgrounds. MSH wanted to extend its services to a wider variety of patients, including the more affluent, by introducing the latest advancements in medicine and surgery. This collaboration began about a year ago and involved numerous discussions on how MSH could enhance care at RMH.
While RMH is wellequipped and technologically advanced, MSH brings expertise in key areas such as cardiology and oncology that are more developed in Western medicine. The partnership aims to bring Western standards of care to Bangalore, including technology and skill development. This involves training medical students and transferring advanced techniques to improve patient safety and expand the scope of procedures performed at RMH. The ultimate goal is to enhance healthcare delivery to Western standards right here in Bangalore.
You mentioned that some surgeries and procedures are not available in the Indian healthcare landscape. Could you specify
which procedures these are?
Dr Sharma: Some advanced surgical procedures, such as those for treating aortic aneurysms and mitral valve repairs, are currently not available in India. For instance, procedures involving transcatheter valve replacement are still under trial in the U.S., but we can bring this technology to Bangalore through our partnership. By introducing these technologies and training local physicians, we aim to make advanced treatments available here before they become widely accessible in the U.S.
This collaboration will certainly benefit the Indian healthcare landscape. What does MSH hope to gain from it?
Dr Sharma: MSH seeks to expand its global presence through such partnerships.
We already have relationships with institutions in China, South America, The primary goal is to enhance MSH's international profile and, of course, there is a financial aspect to it as well. Services provided will come at a cost, but the overarching aim is to extend MSH's global influence and contribute to improving healthcare worldwide.
Can you provide insights into the commercial considerations for both partners and patients?
Dr Sharma: The commercial aspect involves offering advanced surgeries and treatments at RMH that are not available elsewhere. Patients from across India will come to RMH for these specialised procedures. Similarly, trials for cancer drugs and other advanced treatments currently being conducted at MSH can be
extended to RMH. This collaboration will facilitate the introduction of cutting-edge treatments and trials to India, benefiting both patients and the partners involved.
Dr Bahl: Our focus extends beyond commercial benefits. We aim to align with American guidelines and adapt them to the Indian context. For instance, technologies developed for TAVI (Transcatheter Aortic Valve Implantation) and other procedures need to be tailored for the Indian population. We are committed to making these technologies costeffective and relevant to our local needs. This partnership will help us integrate advanced techniques into our practices and ensure that they are adapted to suit our patients' requirements.
How will the technology
transfer and skill-building initiatives be implemented at Ramaiah?
Dr Sharma: The partnership will facilitate technology transfer through hands-on training. Physicians, nurses, and other healthcare staff from RMH will have opportunities to receive training at MSH and bring back the skills needed to use advanced equipment effectively. For example, new technologies such as pulse field ablation for atrial fibrillation will be introduced in India with trained professionals ensuring their proper application.
How will medical students benefit from this collaboration?
Dr Bahl: Medical students will gain immense benefit from this collaboration. They will have the opportunity to spend a month at MSH as part of their training, providing them with exposure to
advanced practices and techniques. Additionally, there will be opportunities for exchange programs where trainees from MSH may visit RMH, and vice versa, to share knowledge and expertise.
Can you discuss how the collaboration will facilitate patient care reviews by experts from MSH?
Dr Sharma: The collaboration will include monthly morbidity and mortality conferences where patient cases are reviewed. These joint conferences, held via Zoom, will allow experts from both hospitals to discuss and assess complex cases, identify potential improvements, and implement best practices. This ongoing review process will help maintain high standards of care and address any gaps in patient management.
Dr Bahl: We are already accredited by Indian agencies and are now pursuing international accreditation. This involves ongoing quality control, infrastructure improvements, and skill transfer. The collaboration allows us to seek second opinions from MSH for complex cases and consider new technologies or treatments. Consultations will be available both on a regular monthly basis and as needed, ensuring timely expert input for complex cases and enhancing patient care.
Are there any latest developments in predictive modelling for heart health assessments?
Dr Sharma: There are various models for assessing heart disease risk, based on different factors and studies. Both American and Indian models consider several risk factors to predict the likelihood of heart disease. Future developments may include adapting these models to local contexts or developing new ones based on emerging research.
How will this collaboration leverage AI to optimise ER admission processes, and what are the research
Dr Sharma: Access to research activities and the potential for Indian patients to participate in clinical trials are key aspects of the collaboration between MSH and RMH. Research trials
from MSH can be conducted at RMH, and new devices or treatments not yet available in the U.S. can be introduced in India. This includes cancer research, where efforts are being made to bring trials to RMH to benefit local patients.
neha.aathavale75@gmail.com
neha.aathavale@expressindia.com
Currently, MSH and RMH do not use AI for emergency room (ER) admissions, although AI is utilised in various other aspects such as detecting falls, patient malnutrition, hypertension, and automatic reading of MRI and CT scans. While ERspecific AI models are not yet in place, future developments may include these applications.
Dr Bilal Thangal TM ,Medical Lead,NURAin an interaction with Kalyani Sharma highlights that while Artificial Intelligence (AI)-enabled imaging shows immense promise in India,there is still progress to be made in overcoming barriers to widespread adoption and integrating these technologies seamlessly into everyday clinical workflows
AI's advancements in medical imaging and predictive analytics will enable earlier detection of diseases
How would you describe the current state of Artificial Intelligence (AI)-enabled imaging in India?
AI-enabled imaging in India is currently undergoing a transformative phase where there is notable adoption in both public and private healthcare sectors. This adoption is primarily driven by advancements in AI algorithms that have greatly enhanced diagnostic accuracy and efficiency in medical imaging. These algorithms are capable of analysing vast amounts of imaging data quickly and detecting patterns that might not be easily visible to human eyes alone.
However, despite these advancements, the integration of AI-enabled imaging into routine clinical practice in India remains gradual. There are several factors contributing to this gradual integration, including regulatory considerations, infrastructure challenges, and the need for validation and trust-building among healthcare professionals. Additionally, there is a requirement for robust training programs to ensure that healthcare providers are equipped with the necessary skills to effectively utilise AI tools in clinical settings.
Overall, while AI-enabled imaging shows immense promise in India, there is still progress to be made in overcoming barriers to widespread adoption and integrating these technologies seamlessly into everyday clinical workflows.
What future trends do you foresee in the field of AI-
enabled imaging in India?
◆ Greater integration of AI in radiology workflows, reducing manual workloads: AI is expected to become more deeply integrated into radiology practices across India. This integration will aim to streamline workflows by automating routine tasks such as image analysis, triage, and report generation. By reducing manual workloads, radiologists can focus more on complex cases and patient care, leading to improved overall efficiency in healthcare delivery.
◆ Improved AI algorithms for better diagnostic precision: Advancements in AI algorithms will continue to enhance diagnostic precision in medical imaging. These algorithms are becoming increasingly sophisticated, capable of detecting subtle abnormalities and patterns in imaging data that might be missed by human observers. This improvement in diagnostic accuracy will contribute to earlier and more accurate disease detection and treatment planning.
◆ Expansion of teleradiology services utilising AI for rural and underserved areas: Teleradiology, which involves the remote interpretation of medical images, is poised for significant expansion in India, particularly in rural and underserved areas. AIenabled imaging solutions can facilitate this expansion by enabling faster image analysis and interpretation, thereby reducing turnaround times and improving access to timely diagnostic services. This trend is crucial for
extending specialised healthcare services to regions where access to radiologists may be limited.
How do you envision AI transforming the overall healthcare landscape in the next decade?
◆ Early detection of diseases through improved imaging and predictive analytics: AI's advancements in medical imaging and predictive analytics will enable earlier detection of diseases. AI algorithms can analyse vast amounts of imaging data with high accuracy, detecting subtle changes or anomalies that may indicate the presence of diseases such as cancer, cardiovascular conditions, or neurological disorders. This early detection allows healthcare providers to intervene sooner, potentially leading to better treatment outcomes and improved patient survival rates.
◆ Precision medicine: Tailored treatment plans based on individual patient data: AI will facilitate the practice of precision medicine by integrating and analysing diverse datasets, including genomic information, electronic health records, and real-time patient data. Machine learning algorithms can identify patterns and correlations within these datasets to personalise treatment plans. This approach considers each patient's unique genetic makeup, medical history, lifestyle factors, and treatment responses, optimising therapeutic efficacy and minimising
adverse effects.
◆ Operational efficiency: Streamlined administrative and clinical workflows: AIdriven automation will streamline administrative tasks such as appointment scheduling, medical record management, and billing processes. In clinical workflows, AI can assist healthcare professionals by analysing patient data, providing decision support tools, and optimising treatment protocols. These efficiencies reduce administrative burdens, enhance productivity, and allow healthcare providers to allocate more time to patient care, ultimately improving overall healthcare delivery.
◆ Patient engagement: Increased patient engagement and education through AIpowered tools like AI bots: AIpowered tools such as chatbots and virtual assistants will enhance patient engagement by delivering personalised health information, answering questions about diagnoses or treatments, and providing ongoing support. These tools empower patients to actively manage their health, improve medication adherence, and adopt healthier lifestyles. By promoting continuous communication and education, AI-powered tools
strengthen the patientprovider relationship and contribute to better health outcomes.
◆ Cost reduction: Lower healthcare costs through efficient resource utilisation and early interventions: AI's impact on healthcare costs will be significant through several mechanisms. By optimising resource allocation and streamlining operations, AI reduces wastage and inefficiencies in healthcare delivery.
Predictive analytics enable early identification of highrisk patients, allowing for timely interventions that prevent costly complications, hospitalisations, and emergency visits. Additionally, AI-driven insights into healthcare data can inform policy decisions and healthcare strategies aimed at improving costeffectiveness across healthcare systems.
Can you elaborate on the benefits of using ultra-lowdose CT scans in healthcare screening?
◆ Reduced radiation exposure compared to conventional CT scans: Ultra-low-dose CT scans utilise optimised imaging protocols that significantly reduce the amount of radiation exposure compared
● Express Healthcare accepts editorial material for the regular columns and from pre-approved contributors/columnists.
● Express Healthcare has a strict non-tolerance policy towards plagiarism and will blacklist all authors found to have used/referred to previously published material in any form,without giving due credit in the industry-accepted format.
● As per our organisation’s guidelines,we need to keep on record a signed and dated declaration from the author that the article is authored by him/her/them, that it is his/her/their original work,and that all references have been quoted in full where necessary or due acknowledgement has been given.The declaration also needs to state that the article has not been published before and there exist no impediment to our publication.Without this declaration we cannot proceed.
● If the article/column is not an original piece of work, the author/s will bear the onus of taking permission for re-publishing in Express Healthcare.The final decision to carry such republished articles rests with the Editor.
● Express Healthcare’s prime audience is senior management and professionals in the hospital industry. Editorial material addressing this audience would be given preference.
to conventional CT scans.
◆ Early detection: Highquality imaging enabling early detection of diseases like cancer: Despite using lower radiation doses, ultra-lowdose CT scans can produce high-quality images that are sufficient for early detection of various diseases, including cancer. Early detection increases the likelihood of successful treatment outcomes by identifying abnormalities or lesions at their earliest stages. This capability is particularly beneficial for screening programs aimed at detecting cancers of the lungs or other organs where early intervention is critical.
◆ Patient comfort: Quick and non-invasive procedure improving patient compliance: Ultra-low-dose CT scans are quick and non-invasive, enhancing patient comfort and compliance during imaging procedures. Patients experience shorter scan times and reduced discomfort, which contributes to overall satisfaction with the healthcare experience. Improved patient comfort encourages participation in screening programs and regular follow-up imaging studies, supporting proactive healthcare management and early disease detection. What are the long-term
goals and future plans for NURA in India's healthcare landscape.
◆ Expansion: Extend screening services to more regions across India and globally: NURA aims to expand its screening services to reach underserved regions across India and potentially expand its footprint globally. By increasing accessibility to screening services, NURA intends to enhance early disease detection and improve health outcomes for populations that may have limited access to healthcare facilities.
◆ Innovation: Continuously incorporate cutting-edge AI technologies: NURA plans to integrate and leverage advanced AI technologies continuously. This includes enhancing AI algorithms for improved diagnostic accuracy, optimising screening workflows, and developing AIdriven tools to support healthcare providers in delivering efficient and effective screening services.
◆ Awareness: Increase public awareness about the importance of early disease detection: Educating the public about the significance of early disease detection is a key goal for NURA. By raising awareness through campaigns, educational programs, and partnerships,
● The articles should cover technology and policy trends and business related discussions.
● Articles by columnists should talk about concepts or trends without being too company or product specific.
● Article length for regular columns: Between 1300 - 1500 words.These should be accompanied by diagrams,illustrations,tables and photographs, wherever relevant.
● We welcome information on new products and services introduced by your organisation for our Products sections.Related photographs and brochures must accompany the information.
● Besides the regular columns,each issue will have a special focus on a specific topic of relevance to the Indian market.You may write to the Editor for more details of the schedule.
● In e-mail communications,avoid large document attachments (above 1MB) as far as possible.
● Articles may be edited for brevity,style,relevance.
● Do specify name,designation,company name, department and e-mail address for feedback,in the article.
● We encourage authors to send a short profile of professional achievements and a recent photograph, preferably in colour,high resolution with a good contrast.
NURA aims to empower individuals to prioritise preven tive healthcare measures and participate in screening programs for early detection and intervention.
◆ Collaboration: Partner with healthcare providers and policymakers to improve screening programs: Collaborating with healthcare providers and policymakers is essential for NURA to enhance screening programs' effectiveness and reach. By forging partnerships, NURA can align screening efforts with healthcare policies, integrate screening into existing healthcare systems, and ensure sustainable support for screening initiatives.
◆ Research: Conduct research to further validate and enhance screening protocols: NURA is committed to conducting research to validate and refine its screening protocols continually. This includes studying the effectiveness of screening methods, evaluating outcomes, and incorporating insights from research to improve screening accuracy, efficiency, and patient outcomes over time.
Kalyani.sharma@expressindia.com journokalyani@gmail.com
Email your contribution to: viveka.r@expressindia.com viveka.roy3@gmail.com Editor, Express Healthcare
Quitable access in healthcare need to be built on pillars of knowledge exchange,funding, infrastructure and technology
ByKalyani Sharma
The disparity inhealthcareinfrastructure between rural and urban areas has long been a topic of concern. Urban areas often benefit from advanced medicalfacilities, a higher concentration ofhealthcare professionals, and better access to cutting-edge technologies. In contrast, rural areas and tier 2 and tier 3 frequently struggle with limited resources, fewerhealthcare providers, and challenges in accessing specialisedcare. However, each setting has developed unique and innovative solutions tailored to its specific challenges, presenting opportunities for cross-learning and adaptation.
Sharing his views on this, Dr S. Gurushankar, Chairman, Meenakshi Mission Hospital and Research Centre, Madurai mentions, “Healthcare in India varies significantly between rural, tier 2 and tier 3 cities, and urban areas. Rural regions often lack quality healthcare, with patients visiting facilities only at the last moment due to limited resources. The doctorto-patient ratio is 1:11082 in rural areas, far from the WHO recommendation of 1:1000. Most doctors practice in urban areas, leaving rural communities dependent on an underresourced public health sector.”
A report by Praxis Global indicates that approximately30 per centof hospital bedsand 50 per centof healthcare facilitiesare situated in rural areas, which account for around 67 per cent of the total population in India. The rural regions exhibit a concerning doctor-to-patient ratio of approximately1:25,000, significantly below the World Health Organization's recommended ratio of1:1000.
Dr Sanjeev Singh, Medical Director, Amrita Hospital Faridabad highlights that understanding the disparities is crucial for developing strategies that ensure equitable healthcare access for all.
Urban areas can adopt personalised care models from rural settings, while rural areas can benefit from urban medical technologies
Dr S.Gurushankar Chairman, Meenakshi Mission Hospital and Research Centre, Madurai
Understanding the disparities is crucial for developing strategies that ensure equitable healthcare access for all
Dr Sanjeev Singh Medical Director, Amrita Hospital Faridabad
Adapting rural innovations to urban settings and vice versa requires a nuanced approach.For instance, telemedicine,successful in urban areas, needs to be tailored for rural regions by addressing connectivity issues and training local healthcare workers
Abrarali Dalal Director and CEO, Sahyadri Group of Hospitals, Pune
Develop a policy framework that incentivises the creation of scalable healthcare solutions adaptable to various settings
Sachidanand Upadhyay MD at Lord’s Mark Industries
He said, “In today's rapidly evolving healthcare landscape, ensuring equitable access to quality healthcare is more critical than ever. While advancements in medical technology and treatment have significantly improved health outcomes in many urban centers, rural and smaller cities often lag behind, highlighting the urgent need for development at all levels. Addressing these disparities is essential for building a healthcare system that serves all populations effectively.”
Abrarali Dalal, Director and CEO, Sahyadri Group of Hospitals, Pune share some stats and said, “According to the National Rural Health Mission, rural India, which accounts for about 70 per cent of the population, has only about 40 per cent of the country's hospital beds. This disparity leads to delayed treatments, increased travel for medical care, and generally poorer health outcomes. According to National Health Profile 2022, the distribution of beds between rural and urban areas is notably imbalanced, with rural hospitals comprising 36.5 per cent of the total beds and urban hospitals holding 63.5 per cent. This highlights significant disparities in healthcare infrastructure between urban and rural settings.”
solutions in urban and rural healthcare
In urban centers, the integration of advanced technology has transformed healthcare, streamlining processes and improving patient outcomes. However, in the vast rural expanses, the heart of healthcare beats differently. Here, community health workers (CHWs) are the lifeline, serving as a crucial link between the community and formal healthcare systems. These unsung heroes navigate challenging terrains and overcome numerous obstacles to deliver essential care, ensuring that even the most remote villages have access to vital health services.
Talking about the innovation in urban healthcare, Dr Singh emphasises, “Telemedicine & Tele ICU for example, has revolutionised access to specialist care in urban settings and can be instrumental in bridging the gap in rural areas. Additionally, urban centers often implement comprehensive electronic health record (EHR) systems that streamline patient information and enhance care coordination. Adapting these technologies to fit the context of smaller cities and rural areas can significantly improve the efficiency and quality of care provided in these regions.”
Explaining the pivotal role of CHWs in rural healthcare delivery, Dalal shares that they act as a bridge between the community and formal healthcare systems. These workers, often locals trained in basic healthcare practices, provide essential services such as maternal and child health care, immunisations, and health education. Another notable innovation is the use of solarpowered healthcare facilities, which ensure uninterrupted power supply for critical medical equipment in areas with unreliable electricity.
Programs like the
Accredited Social Health Activist (ASHA) scheme train local women to provide basic healthcare services, significantly improving maternal and child health outcomes. In Maharashtra, ASHA workers have been instrumental in reducing maternal and infant mortality rates. By providing antenatal care, educating mothers about nutrition, and ensuring timely immunisations, ASHA workers have created a healthier community. Their efforts have led to a significant decrease in maternal deaths and improved overall health indicators in the region.”
Atwo-waystreet of learning
Dr Gurushankar stresses that urban and rural healthcare systems can learn from each
Rural areas have pioneered cost-effective healthcare models. Innovative hybrid models integrating eClinics,digital franchisees,and a network of healthcare providers demonstrate how technology and empathy can bridge critical healthcare gaps
Priyadarshi Mohapatra Founder & CEO, CureBay
The growing number of hospitals in tier 2 and tier 3 cities expands the market for medical devices.Manufacturers can tailor their products to meet the specific needs and affordability constraints of these cities
Aryaman Tandon Managing Partner,Healthcare,Praxis Global Alliance
other to create a more robust network. Urban areas can adopt personalised care models from rural settings, while rural areas can benefit from
urban medical technologies. By embracing collaboration, we can build a healthcare system that serves all populations, bridging the gap
between rural, tier 2 and tier 3 cities, and urban areas.
Priyadarshi Mohapatra, Founder & CEO, CureBay opines that rural areas have
pioneered cost-effective healthcare models. Innovative hybrid models integrating eClinics, digital franchisees, and a network of healthcare providers demonstrate how technology and empathy can bridge critical healthcare gaps. These models often include significantly reduced consultation fees, discounted rates on medications, and membership programs that offer comprehensive benefits such as complimentary consultations, diagnostic examinations, reduced prices on medications, and access to ambulance services and other amenities. These initiatives highlight the need for accessible and economical healthcare services in remote regions.
Dalal also opines, “Adapting rural innovations to urban settings and vice versa requires a nuanced approach. For instance, telemedicine, successful in urban areas, needs to be tailored for rural regions by addressing connectivity issues and training local healthcare workers. Conversely, urban areas can adopt the CHW model by modifying it to fit the urban context, focusing on health education and preventive care in underserved urban communities.”
According to Dr Singh, to successfully adapt rural innovations to urban settings and vice versa, it is crucial to consider the unique characteristics of each environment. Strategies should include flexible implementation plans that respect local contexts and involve stakeholders from both rural and urban areas. For example, urban centers can adopt the community engagement models from rural areas to enhance preventive care, while rural areas can implement scalable versions of urban telemedicine platforms to improve specialist access. The key is to tailor these innovations to meet the specific needs of each community. The growth of hospitals in tier 2 and tier 3 cities in India has the potential to create
substantial opportunities for various stakeholders in the healthcare industry, including diagnostic service providers and medical device manufacturers.
Aryaman Tandon, Managing Partner, Healthcare, Praxis Global Alliance shares some interesting insights on the same and said, “Diagnostic labs can offer cost-effective testing options without compromising on quality to cater to the price-sensitive segment. Establishing collection centers in easily accessible locations within tier 2 and tier 3 cities and mobile collection units to reach surrounding remote areas can help unlock the potential. Companies can partner with local hospitals and clinics to offer diagnostic services. They can also work with government health departments to participate in public health programs and screenings, enhancing brand visibility and credibility. Developing lower-priced test packages tailored for the local population, such as comprehensive health check-ups, along with home collection services, can provide a competitive edge while enhancing convenience and customer satisfaction.
Similary for medical device manufacturers, “The growing number of hospitals in tier 2 and tier 3 cities expands the market for medical devices. Manufacturers can tailor their products to meet the specific needs and affordability constraints of these cities. As healthcare facilities in these cities upgrade and modernize, there is an opportunity for medical device manufacturers to provide advanced and innovative technologies, such as telemedicine tools and pointof-care devices.”
Equitable access in healthcare need to be built on pillars of knowledge exchange, funding, infrastructure and technology.
Sachidanand Upadhyay,
MD at Lord’s Mark Industries
Source: Praxis Global
◆ Community Engagement: Rural healthcare often thrives on strong community ties and trust.Urban providers can learn to build deeper connections with their communities to improve patient engagement and adherence to treatment plans.
◆ Personalised care: The smaller scale of rural healthcare often allows for more personalised and holistic patient care.Urban healthcare can benefit from incorporating more patient-centered approaches and continuity of care.
◆ Advanced technology and specialisation: Urban healthcare facilities typically have access to advanced technologies and specialised medical expertise.Rural healthcare can seek partnerships or telemedicine consultations to leverage these resources.
◆ Comprehensive training and education: Urban centers often provide more extensive training and continuing education opportunities.Rural healthcare providers can establish connections to urban institutions for ongoing professional development.
◆ Infrastructure and scalability: Urban healthcare systems often have better infrastructure and scalability models.Rural healthcare can learn from urban systems' infrastructure development and efficient management of larger patient volumes.
◆ Data analytics and research: Urban healthcare systems frequently utilise data analytics to improve patient outcomes and operational efficiency.Rural healthcare can adopt these analytical tools to better understand and address their unique challenges.
◆ Diverse services and specialists: Urban healthcare offers a wide range of specialised services.Rural providers can develop referral systems and collaborations to ensure their patients have access to necessary specialised care.
shares, “Develop a policy framework that incentivises the creation of scalable healthcare solutions adaptable to various settings. This should include subsidies for companies that successfully implement innovations across different environments. Implement grant programs that fund collaborative initiatives between urban innovators and rural healthcare providers. These grants should support pilot projects that adapt urban
technologies for rural applications and vice versa. Develop comprehensive technology networks that connect urban and rural healthcare systems, facilitating real-time data sharing, telemedicine consultations, and remote diagnostics. This approach promotes mutual learning and the adaptation of best practices. Establish mobile innovation labs that travel between urban and rural areas to demonstrate new technologies and
gather feedback. These labs will enable hands-on learning and the customisation of solutions for diverse environments and Create mentorship programs where urban healthcare leaders assist rural counterparts in adopting advanced technologies, while rural providers offer insights on resourcefulness and community engagement.
Dr Singh highlights that Policy recommendations play a vital role in fostering innova-
The growth of hospitals in tier 2 and tier 3 cities in India has the potential to create substantial opportunities for various stakeholders in the healthcare industry manufacturer
tion exchange between different healthcare systems. Governments and healthcare organizations should establish frameworks that encourage collaboration, funding, and knowledge sharing between rural, tier 2 and tier 3 cities, and urban areas. Policies should support pilot programs, provide financial incentives for adopting successful models from other regions, and facilitate the integration of innovative technologies. By creating an environment conducive to innovation exchange, we can ensure that all populations benefit from advancements in healthcare, leading to improved health outcomes nationwide.
Equitable access to healthcare is not just a goal; it is a necessity for a healthy society. The journey towards healthcare equity requires commitment and collaboration from all stakeholders, including governments, healthcare providers, and communities.
Kalyani.sharma@expressindia.com journokalyani@gmail.com
Axonic introduces an innovative corporate wellness program under its service brand,“AxonCare,” and it is all set to grab all the corporates' attention
Axonic, a leading global health-tech brand, is proud to announce the launch of its AxonCare Corporate Wellness Program, a groundbreaking initiative designed to revolutionise employee well-being. This comprehensive program aims to provide corporations with a holistic approach to employee healthcare, boosting productivity and enhancing overall company culture.
The AxonCare Corporate Wellness Program offers a range of benefits, including:
◆ On-site AxonCare clinics: Conveniently located within corporate premises, these clinics provide employees easy access to essential healthcare services.
◆ Daily vital checks: Regular
This
comprehensive program aims to provide corporations with a holistic approach to employee healthcare,boosting productivity and enhancing overall company culture
monitoring of vital health parameters helps identify potential health issues early on.
◆ Instant consultations: Employees can seek immediate advice and guidance from healthcare specialists.
◆ Appointment scheduling: Easy booking of appointments with specialists ensures timely care.
◆ Comprehensive health management: AxonCare empowers employees to take control of their health and well-being.
◆ Mental health and wellness support: Create a happy, motivated and productive workforce with the help of our mental wellness experts.
◆ Customise your program: The AxonCare Corporate Wellness Program is tailored to fit your corporation's unique needs and objectives, guaranteeing a personalised approach that delivers maximum impact.
Dr Abhay Chopada, Founder of Axonic said, "We believe that a healthy workforce is a productive workforce. The AxonCare Corporate Wellness Program is our commitment to supporting businesses in creating a healthier and happier work environment."
By investing in the health and well-being of their employees, corporations can significantly improve morale, reduce
absenteeism, and enhance their employer brand. The AxonCare Corporate Wellness Program is a strategic solution that delivers tangible benefits to employees and employers. Be a part of a healthcare revolution with AxonCare by Axonic.
To learn more about the AxonCare corporate wellness program, log on to our website, Corporate Wellness - (axonichealth.com).
About Axonic
Axonic is a global health-tech brand dedicated to revolutionising healthcare delivery. Through innovative solutions and cutting-edge technology, Axonic is committed to improving the health and well-being of people worldwide.
In pursuit of its ambitious plan for the Indian market,Sysmex India has set up a state-of-the-art reagent manufacturing facility in Baddi,Himachal Pradesh
Sysmex India, an in-vitro diagnostic (IVD) company, headquartered in Mumbai, backed with over 250 dedicated skilled professionals spread across India, has already expanded its footprint in the Indian market. It offers a comprehensive range of solutions in the field of clinical laboratory testing, including haematology, haemostasis, urinalysis, clinical chemistry, flow cytometry, life science and scientific services. With its advanced analysers and reagents, it has achieved a strong customer base comprising government & private hospitals, stand-alone labs, chain labs, blood banks, primary centers,
R&D centers, medical institutes among others. As a total solution provider, the company has a dedicated customer service center providing comprehensive support to its clients.
Previously, Sysmex India marketed its products in India through its distribution partner, which has now been discontinued.
In pursuit of its ambitious plan for the Indian market, Sysmex India has set up a state-ofthe-art reagent manufacturing facility in Baddi, Himachal Pradesh. Additionally, to meet the increasing demand in India, it has made significant investment to build a new plant in Sanand,
Ahmedabad, India. This strategic move will ensure a stable supply of products to the Indian market. Notably, the new plant will follow an environmentally sustainable model, featuring high quality products, high efficiency manufacturing processes and an advanced zero liquid discharge systemto eliminate water discharge outside the factory site.
Anil Prabhakaran, Managing Director, Sysmex India, reiterated the company’s commitment to the Indian healthcare industry, he stated, “Sysmex is dedicated to scaling up diagnostics for a better healthcare journey. We are committed to deliver
quality products, backed by Japanese cutting-edge technology, and unmatched service. With a clear roadmap and robust strategy, Sysmex India aims to establish itself as the market leader in India.”
About Sysmex Sysmex Corporation, headquartered in Kobe, Japan, is a global leader in in vitro diagnostics. Since its foundation in 1968, Sysmex has focused on diagnostics as the core of its business, and today, it supports the health of people in over 190 countries and regions worldwide. Sysmex India Pvt. Ltd, an affiliate of Sysmex Corporation, has been serving the healthcare industry in India
since 2012 as an IVD company, and provides comprehensive diagnostic laboratory solutions Sysmex continues to innovate in diagnostics, and to collaboratively create unique values in the areas of personalised medicine and novel treatments, under its long-term vision of "Together for a better healthcare journey." Through its unique technology, solutions, and cocreation with various partners, Sysmex delivers new value and addresses the universal desire of people to live longer and healthier lives.
For more information, please visit www.sysmex.co.in
The monsoon season brings much-needed relief from the summer heat but also introduces a myriad of health challenges.Increased humidity,water stagnation,and a surge in pathogen activity can lead to various health issues ranging from water-borne diseases to viral infections. Experts share insights to empower readers with the knowledge needed to navigate the health challenges of the rainy season effectively
DR DIVYA GOPAL
Consultant-Internal Medicine, Sir H.N.Reliance Foundation Hospital
Taking the right precautionarymeasures at the right time Dengue-causing Aedes aegypti mosquito breeds in stagnant water (such as in buckets, drums, flower pots, wells, and tree holes). With the change in landscapes and urbanisation, these organisms have adapted themselves and are now found in urban homes as well. The incubation period of dengue fever is four to seven days after being bitten, and the first signs include fever and fatigue.
Chikungunya, caused by the Aedes albopictus mosquito, is a non-fatal viral disease. These mosquitoes breed in stagnant water and can bite you not only during the night but also during the day. ‘Chikungunya’ means that which bends up and is called so because of its distinct arthritic symptoms (pain in the joints and bones, stiffness).
DR SHALMALI INAMDAR
Consultant,Physician And Adult Infectious Diseases,Kokilaben Dhirubhai Ambani Hospital Mumbai
When do you need hospitalisation?
In adults, high-grade fever lasting more than 48 hours, altered sensorium, breathlessness, chest pain, and bleeding should require prompt medical attention. In dengue, the danger period is while the fever is settling down. Children with dengue and warning signs such as vomiting, stomach pain, restlessness, lethargy, and bleeding need admission for close observation. In malaria, a child who is unable to sit, stand, or drink needs admission. Those with impaired consciousness, fits, scanty urine, breathing difficulty, or jaundice should be admitted.
DR KAVITA KRISHNA
Director of Medicine & Rheumatology,Sahyadri Super specialityHospital,Hadapsar, Pune
Preventing mosquito-borne diseases requires multifaceted approach
Public health campaigns should focus on eliminating mosquito breeding sites, especially in urban areas like Mumbai and Pune, where stagnant water in containers, construction sites, and garbage can serve as breeding grounds. Utilising insecticides in these areas can further reduce mosquito populations.
DR MALA KANERIA
Consultant,Infectious Diseases- JaslokHospital & Research Centre, Mumbai
Mosquito which transmits dengue and chikungunya bites in the daytime
Oneshould be aware that the mosquito which transmits dengue and chikungunya bites in the daytime. Preventing the accumulation of water in water bodies (stored water containers, plates below the potted plants, old tyres, etc) is a key measure in preventing the formation of mosquito larvae).
DR RAHUL TAMBE
Senior consultant, Internal Medicine, Nanavati MaxSuper Speciality Hospital,Mumbai
Antimalarial medications are used to treat malaria
Antimalarial medications are used to treat malaria and p revent the symptoms from aggravating. On the other hand, dengue treatment focuses on hydration and pain relief, as there is no specific antiviral treatment. Less than 2 per cent of these patients require hospitalisation.
DR BHARAT AGARWAL
Consultant-Internal Medicine, Apollo hospitals,Navi Mumbai
Good hygiene practices are foundational Colds, while typically mild, can disrupt our daily lives with persistent symptoms like a runny nose, sore throat, and cough, making even the simplest tasks feel daunting. The flu, on the other hand, is much more debilitating, bringing with it high fever, intense chills, muscle aches, and extreme fatigue that can put a significant strain on our bodies and spirits.
Managing these infections is not just about addressing physical symptoms; it’s also about emotional and psychological resilience. Good hygiene practices, such as regular handwashing and avoiding close contact with those who are sick, are foundational.
DR RONAK TATE
Consultant Gastroenterology, Fortis Hiranandani Hospital Vashi
Importance of clean water and sanitation
Diseases like Diarrhea, Dysentery, Cholera, Jaundice and Typhoid are water borne diseases which spread because of drinking unsafe contaminated water. Clean water is not necessarily potable water, safe for human consumption. Water from natural sources like lake, pond, or even a well need to be boiled for 10 minutes after it reaches boiling point, thus killing germs in it. However, water from water purifier is safe for drinking without any further processing.
DR UMANG AGRAWAL
Infectious Diseases Consultant, P.D.Hinduja Hospital & Medical Research Centre
Get vaccinated I strongly recommend getting the flu shot every year. It is a preventable disease, and the consequences of not getting vaccinated are much more serious. Therefore, I urge everyone to get vaccinated as soon as possible.
VARSHA GOREY
Senior Clinical Dietitian,HOD, Dietetics,Apollo Hospitals
Vitamins and minerals are pivotal in fortifying our immune system
DR VINAY DHIR
Chairman-Institute of Digestive & Liver Care,SLRaheja Hospital, Mahim
Contaminated water is the source Hepatitis A, Typhoid and Cholera
Contaminated water is the source of a variety of monsoon illnesses like Hepatitis A, Typhoid and Cholera. Hepatitis A is caused by a virus which infects our Liver and causes Jaundice. Most of these cases happen in children, and they usually recover in few weeks’ time. Occasionally the disease may become severe, needing hospitalisation. Typhoid is caused by a bacterium which enters our system through contaminated water or food. It causes fever and abdominal symptoms. If diagnosed properly, can be treated easily with antibiotics. Cholera is also caused by contaminated water or food. It causes severe diarrhea and dehydration. Hospitalisation is needed for hydration and antibiotic treatment. Practicing good water and food hygiene can prevent all these diseases.
Adiet abundant in fruits and vegetables not only provides essential nutrients but also brings a touch of brightness to our meals. In addition to a balanced diet, probiotics and herbal supplements offer a sense of reassurance, providing both physical benefits and emotional comfort. Vitamins such as C and D, and minerals like zinc and iron, are pivotal in fortifying our immune system, symbolising our commitment to selfcare. Incorporating Indian natural antioxidants like basil further enhances our defense mechanisms.
Focus on eating the right things at the right time
Boosting the immune system is possible only if lifestyle changes are made. Focus on eating the right things at the right time and interval and keeping the body hydrated well. Some exercise to be planned (150 min /d) Need to manage sleep at least 8 hrs. Manage stress by planning meditation or stress relieving activities. The diet should be full of vegetables and fruits. Whole grains, healthy fats and lean proteins. Waterborne diseases are more common in monsoon so water intake should be with precaution. Boil water is recommended always. Avoid tap water directly. Vegetables like methi, bitter gourd, and Neem Turmeric can be included in the diet to prevent infection.
Shobha Mishra Ghosh,Director-Government Affairs & Policy,GE HealthCare
South Asia share her views on budget 2024-25
The first post-election budget has been skillfully crafted to be one of the most creative and forwardthinking budgets in the times. With the electoral mandate focusing on ‘development and employment’, especially with the youth, poor, women, and farmer at the center stage of the nine pillars of the budget, it looks like a well-defined and well paved path to Viksit Bharat and Amrit Kaal vision by 2047.
As per World Bank 2021 analysis, without good health conditions, an economy loses its ability to develop competitive productivity, which might subsequently hinder economic growth. With the budget 202425 promising to leverage opportunities and strengthen the four vectors, i.e the supply side, demand side, innovation and R&D and in relevant sectors including healthcare, the pragmatic approach is encouraging for the sector.
Growing incidences of communicable and non-communicable diseases with a burgeoning senior citizen population make for a propelling case for increasing public spend on health from current 1.9 per cent to 2.5 per cent of GDP by 2025, as per the National Health Policy 2017 with a 3 per cent GDP in next couple of years.
The budget announcement on reducing the cost of three crucial cancer care drugs is pertinent as it shows the criticality of the disease burden pummeled by both communicable and NCDs. The call of the hour is to further expand PMJAY coverage limit from Rs 5 lacs to 10 lacs to cover end-to end cancer care solutions including screening, diagnostics, advanced treatment like immunotherapy and precision medicine and palliative care.
With the budget 2024-25 promising to leverage opportunities and strengthen the four vectors,i.e the supply side, demand side,innovation and R&D and in relevant sectors including healthcare,the pragmatic approach is encouraging for the sector
According to the United Nations Population Fund (UNFPA), In-
dia's one-fifth of population will comprise people above 60 by 2050. There is a growing concern of rising incidence of cardiac arrests, stroke, dementia
and Alzheimer. The need of the hour is to protect this vulnerable segment of population from all economic strata. The PMJAY coverage, as announced in the electoral manifesto must include 70 years and above, who are devoid of any kind of social security. The focus on maternal and childcare and women-oriented cancers like cervical, ovarian and breast cancer will continue.
Expanding healthcare infrastructure
The increased budget outlay for health by 12.97 per cent to Rs 90958.63 Cr from last year’s outlay substantiated by States will speed up the expansion of primary, secondary and tertiary care across geographies in India. The increased access to quality healthcare would create demand for specialized medical infrastructure, medical technologies and skilled workforce for quality health delivery.
Impact on the ‘Supply’side
Post-COVID era has seen both, the Central and State governments proactively reaching out to domestic and foreign OEMs with attractive investment propositions through subsidies and incentives.
To continue the momentum of local manufacturing in medtech sector, the budget for PLI scheme has been increased to 40.9 per cent over last year budget to Rs 85 Cr. While this is definitely an encouraging step, the scheme needs simplification, streamlining, expanding it to brownfield facilities and including components and subcomponents in the scheme for easy adoption by the manufacturers.
Further, exemptions of custom duties on specialized raw materials and reduction of custom duty from 15 per cent to 5
per cent on X-ray tubes and flat panels detectors is a good indicator for the investors. This would help in bringing down the local manufacturing costs and address the concern regarding 12-15 per cent disabilities faced by the industry owing to lack of infrastructure, skilled workforce, land, electricity, water etc. The announcement of “comprehensive review of the rate structure for ease of trade, removal of duty inversion and reduction of disputes” will further improve the investment attractiveness. Towards rationalization of duties to bring down the cost of local manufacturing, one suggestion is to segregate HSN codes for differential custom duties for imports of finished goods, components & raw material. This segregation of HSN code has recently been announced for exports by DGFT.
The positive indicators in the budget, combined with policy and regulatory stability will attract investments and increase the FDI inflows for medtech across all segments from current USD 3.28 billion (Invest India data). The proof of the pudding is the recent announcement of USD 1 billion investment over next 5 years on manufacturing and R&D by Wipro GE Healthcare. Increased localization with indigenous growth of local content aided by innovation will also help grow the exports that currently has surpassed the USD 4 billion million mark as per data from Department of Pharmaceuticals.
Industry welcomes the operationalisation of Anusandhan National Research Fund for basic research and prototype development and private sectordriven research and innovation
at commercial scale with a financing pool of Rs 1 lakh crore. This would prove vital for the projected economic growth and help India to move from volume to value manufacturing. Implementation of PRIP scheme with allocated budget of Rs 75 cr needs to be fast tracked for timely results.
While deriving demographic dividends due to young demography is encouraging, it also poses the challenge of access to education, relevant skilling and job creation considering the daunting population size. The three employment generation schemes announced for 300 lakh (30 million) youth, MSME and large corporates budget, creatively addresses the challenges to give a positive thrust to make youth future-ready, and boost manu-
facturing in the country. Incentivising skilling and job creation by providing cash in hand to youth on one hand and encouraging MSME and large industry to use their CSR funds to train and employ is a step in the right direction.
The provision of Rs10 lakh education voucher to 1 lakh (100000) and Rs 7.5 lakh skill loans to 25000 youth for industry relevant skilling with a guarantee from government promoted fund is a muchneeded move to prepare youth for higher levels of jobs. This will help in addressing the current lack of highly skilled engineers, researchers, clinical experts and shop floor technicians in the sector, to navigate through complex and advanced combination of bioengineering, electronics, software engineering, AI/ML, data analytics, 3D printing etc.
next steps: Bracing the healthcare sector for the coming decade
The budget, this year, thus, continues to prioritise on reducing import dependencies, building resilient supply chain and global competitiveness of Indian manufacturer. The government needs to include the above recommendations in the 100-day agenda and fast track implementation.
In addition, compliance to Land Border Order in medtech industry across the country is extremely crucial for maintaining patient safety and protecting national security due to storage of population health data in medical devices. This is also critical to provide level playing field to local manufacturers to compete in the domestic and foreign markets with aggressive dumping of low-cost low value Chinese medical de-
vices protected by their government.
Further, the increasing cost of logistics due to geo-political reasons combined with deficiencies in capacities, transport infrastructure, intermodal connectivity, warehousing and cold chain, skilled manpower etc. makes medtech manufacturing unviable and unattractive compared to China, Indonesia, Mexico etc. The recently launched National Logistic Policy 2023 is much needed intervention by the government. These needs fast-track implementation with focused sectoral approach through PPP mode with adequate subsidies and incentives.
To become medtech manufacturing hub by 2030, the country must provide end to end solution repair services of ‘Made in India’ medical devices. However, India currently is not an attractive destination for re-
pairs due to current policy of permitting imports of 4–7-yearold products/parts for repairs while average age of medical devices is 10-15 years. The upcoming repair policy framework needs to include this aspect specific to medical devices.
To sum it up, this budget identifies the ‘WHAT’ needs to be done. The ‘HOW’ requires good governance and timely implementation of interventions announced by the government and responsible and effective participation from industry. The 9th pillar in the Budget‘NEXT GENERATION REFORMS’ would be the key to achieve the vision of ‘Viksit Bharat’.
Disclaimer: This article is a promotional feature and does not have journalistic/editorial involvement of Express Healthcare. The content is for information purposes only.
Pioneering advances in interventional cardiology spread through global collaboration
The Indo Japanese CTO Club (IJCTO) 2024, held recently in Hyderabad, India, showcased important advancements in Chronic Total Occlusion (CTO) treatments, driven by robust global collaboration and technological inn ovations. Led by Dr V Surya Prakasa Rao and supported by Canon Medical Systems, the conference underscored India's rapidly advancing capabilities in CTO interventions, mirroring achievements seen in Japan. Discussions and presentations highlighted impact of Canon Medical's aEvolve Imaging and ECG Sync technologies, promising enhanced procedural precision and safety in complex Interventional Cardiology procedures
Chronic Total Occlusion (CTO) is a complete or nearly complete blockage of one or more Coronary Arteries. The blockage is caused by a buildup of plaque within a coronary artery that compromises blood flow to the heart. CTO is common in patients withcoronary artery disease. Around 20-25 per cent of patients with Coronary Artery Disease also have a chronically blocked artery. Successful treatment requires intricate procedures. However, Interventional Cardiologists are able to achieve better and better success rates in treating CTO thanks to advances in technology, as well as international collaboration that accelerates the exchange of knowledge on new innovations and techniques. In addition to bringing new innovative solutions to Interventional Cardiologists, Canon Medical Systems provides support for academic forums that enhance learning and progression.
Dr V. Surya Prakasa Rao, Chairman of the Indo Japanese CTO Club (IJCTO) 2024 and
Director of Interventional Cardiology at Care Hospital Banjara Hills, Hyderabad, India said, "The average success rate of CTO treatment in India has reached almost 90 per cent in the last few year. This is similar to achievements in Japan. It has been made possible by cooperation between India and Japan through platforms like the IJCTO and advancements in hardware, angio-systems, and procedural improvements.
In particular, workshops like IJCTO help practitioners achieve perfect CTO PCI. These efforts have contributed to the 90 per cent success rate of Indian CTO treatment in recent years,"
Aprestigious academic partner: IJCTO was founded in 2012 in collaboration with the Japanese CTO Club.
It has become a prestigious
academic partner in Interventional Cardiology, especially for CTO (Coronary Total Occlusion).
This year, IJCTO 2024, was held from June 7 to 9 in Hyderabad, India. The conference attracted approximately 800 Interventional Cardiologists who specialise in CTO treatments from across India. Within this number were many Interventional Cardiologists from Southeast Asian countries. A new Women's Cardiology forum was included in the IJCTO program this year.
Dr Kenya Nasu, Vice President of Mie Heart Center, Mie, Japan, and Chairperson of CTO Club NAGOYA, IJCTO 2024 said, “As of 2012, Japan was more advanced in CTO treatment, but recently, India's CTO treatment techniques have become comparable to those in Japan. I felt that the technology and knowledge regarding CTO have improved significantly compared to before."
"So far, the conference has been built up over the past ten years on the relationship between only Indian and Japanese practitioners,” remarked Dr Rao. “However, in the near future, we would like to expand this academic interaction to other regions, including countries in Southeast Asia and the Middle East. I would like to see advances in technology and hardware spread to many continents, and India is now working at the same level as other countries."
IJCTO 2024 featured a joint seminar co-hosted by Indian and Japanese doctors, and supported by Canon Medical Systems Corporation entitled: “CTO CLUB NAGOYA@UCTO 2024.". During the seminar, Dr Shunsuke Matsuno, Director of the Interventional Cardiology Department at The Heart Institute, Tokyo, Japan, gave a presentation on Canon Medical System’s aEvolve Imaging.
Canon Medical’s new Alphenix Evolve Edition Angiography system, which was introduced in August 2023, has opened new windows of opportunity for Interventional Cardiologists. Unique Deep Learning technology with real-time application enables users of the Alphenix Evolve Edition to enhance imaging and reduce the time and radiation dose required for routine and complex Interventional Cardiology procedures, such as CTO, as well as Percutaneous Coronary Intervention (PCI) and Structural Heart Disease (SHD) treatments. The results are increased success in these intricate procedures and improved safety for clinicians and patients.
In his presentation at IJCTO, Dr Matsuno highlighted that aEvolve Imaging allows physicians to reduce the radiation dose without compromising image quality. And furthermore, that it enables physicians to perform DA-less
PCI by providing DA-like Fluoro images.
Alongside aEvolve Imaging, Dr Matsuno introduced ECG Sync*. ECG Sync is an application that synchronises X-ray irradiation with the ECG wave, reducing image blurriness caused by the heartbeat and obtaining static images.
ECG Sync supports physicians in safely guiding wire delivery with confidence and contributes to reducing irradiation frequency.
“ECG Sync can assist physicians in PCI, especially in complicated and time- consuming cases like CTO, with a very low dose,” said Dr Matsuno.
"It will take some more years to launch ECG Sync into the market, but we have high expectations that using ECG Sync can reduce the dose for CTO treatments that require longer fluoroscopy," Dr Rao added.
Continual collaboration:
The future of CTO treatment looks promising with continued international collaboration and innovation at events such as IJCTO. The advancements in technology and the spirit of academic exchange push the boundaries of Interventional Cardiology towards creating a brighter and healthier future for patients worldwide.
"CTO Intervention in India has been quite successful over the last decade because of the fruitful collaboration between Japanese and Indian doctors,” said Dr Sharath Reddy An-
nam, Director of Interventional Cardiology at Medicover Hospital Hyderabad, India, and Course Co-Director of IJCTO 2024. “Moving forward, this collaboration should continue. That's crucial because most inn ovations happen in Japan."
He also pointed out the need for better training programs: "What is lacking in India now is proper fellowship training for fellows,” he added.
“We strongly hope that Japanese institutions will collaborate with us to welcome the next generation of Indian CTO Interventionists for fellowship programs and inspire them."
"Rather than going to India to teach something, we are shifting towards sharing our extensive experience with Indian doctors. It is true that the technical level of expert Indian doctors is improving, but India is a large country with a wide range of treatment needs, so there are many more potential Indian doctors who need educational opportunities,” explained Dr Nasu “Currently, the educational environment, including CTO treatment, is entering a phase where the educational programs are being created by Indian doctors. Collaborating with Indian doctors in educational positions and providing indirect support will be our contribution from Japan."
With India's growing expertise and the sustained support from Japan, the world can expect groundbreaking devel-
opments in CTO treatments and beyond. The future is bright for CTO Intervention, with innovations and collaborations paving the way for even greater achievements in the field.
Note: *As of Now, ECG Sync is available only for Japanese market.
Find out more about IJCTO 2024 here: https://www.ijcto2024.com
Find out more about Canon Medical’s new Alphenix Evolve Edition Angiography system here: (link to relevant product pages on the website here)
Find out more about Canon Medical System’s Interventional Cardiology Solutions here: (links to relevant web pages here)
Possible floating quote: "The average success rate of CTO treatment in India has reached almost 90 per cent in the last few years. This is similar to achievements in Japan. It has been made possible by cooperation between India and Japan through platforms like the IJCTO and advancements in hardware, angiosystems, and procedural improvements.”
Dr V. Surya Prakasa Rao, Chairman of the Indo Japanese CTO Club (IJCTO) 2024 and Director of Interventional Cardiology at Care Hospital Banjara Hills, Hyderabad, India.
Himanshu Baid,MD,Poly Medicure mentions that delving into how India can leverage favorable government policies,strategic investments,and a robust ecosystem of talent and innovation to harness its immense potential and become the global hub for medtech is crucial
In recent years, India's medtech industry has emerged as a beacon of growth, poised to redefine healthcare on a global scale. Delving into how India can leverage favorable government policies, strategic investments, and a robust ecosystem of talent and innovation to harness its immense potential and become the global hub for medtech is crucial.
India's journey towards becoming a global medtech leader is significantly bolstered by the government's proactive policies aimed at fostering growth and innovation in the sector. Initiatives such as 'Make in India' have provided a strong impetus for domestic manufacturing. These policies not only promote self-reliance but also enhance India's competitiveness in the global market.
Moreover, the government's focus on simplifying regulatory frameworks and ensuring faster approvals for medical devices has streamlined the path to market entry. This has attracted increased Foreign Direct Investment (FDI) into the healthcare sector, reinforcing India's position as an attractive destination for global investors seeking growth opportunities in medtech.
India boasts a wealth of technical talent, with a vast pool of skilled engineers and scientists capable of driving innovation across various domains of medical technology. Our economical yet highly proficient workforce has been instrumental in advancing research, development, and manufacturing capabilities in the medtech sector. This technical prowess not only supports indigenous innovation but also positions India as a cost-effective hub for developing high-
While 'Make
in India'
continues to be pivotal,the focus is
now
expanding to 'Design,Innovate & Make
in India'.This evolution underscores India's commitment to nurturing a culture of innovation where companies are encouraged to design cuttingedge medical solutions tailored to global standards
quality medical devices. While 'Make in India' continues to be pivotal, the focus is now expanding to 'Design, Innovate & Make in India'. This evolution underscores India's commitment to nurturing a culture of innovation where companies are encouraged to design cutting-edge medical solutions tailored to global standards. By fostering an ecosystem that supports R&D, intellectual property protection, and commercialisation of innovations, India will pave the way for breakthroughs that address critical healthcare challenges worldwide.
The rise of healthtech startups specialising in artificial intelligence, robotics, IoT, and other transformative technologies is reshaping the medtech landscape. These startups are at the forefront of developing solutions that enhance healthcare delivery, improve patient outcomes, and optimise healthcare costs. India's supportive environment for startups, including incubation centers, funding initiatives, and regulatory incentives, is nurturing a vibrant ecosystem where innovation thrives.
In addition to advancing medical technologies, India is
placing a significant emphasis on preventive healthcare and home care solutions. By promoting wellness and early intervention, we aim to reduce the burden on healthcare infrastructure while improving the quality of life for millions. Innovative devices and technologies that enable remote monitoring, telemedicine, and personalised healthcare are poised to revolutionise healthcare delivery in both urban and rural India.
Collaboration between industry, government, and academia is critical to driving innovation and scaling up manufacturing capabilities in the medtech sector. Industry-academia partnerships facilitate knowledge exchange, skill development, and collaborative research, laying the foundation for sustainable growth and competitiveness. By aligning educational curricula with industry needs and fostering joint initiatives, we ensure a steady pipeline of skilled talent equipped to tackle future challenges.
Ensuring a robust supply chain of high-quality raw materials is essential for maintaining global standards in medical device manufacturing. Collaborations across industries to develop and supply medical-grade materials strengthen our manufacturing capabilities and reduce dependence on imports. This strategic approach not only enhances product reliability but also supports India's goal of becoming a preferred supplier of medical devices globally.
Adhering to stringent quality standards is non-negotiable in the medtech industry. India is committed to aligning its regulatory frameworks with international benchmarks to ensure the safety, efficacy, and reliability of medical devices manufac-
tured here. By investing in state-of-the-art manufacturing facilities and adhering to Good Manufacturing Practices (GMP), we demonstrate our commitment to excellence and build trust with global partners and consumers.
International collaborations and alliances play a crucial role in enhancing India's global footprint in medtech. Partnerships for technology transfer, joint research ventures, and market expansion initiatives will enable Indian companies to access global markets, leverage best practices, and co-innovate with international counterparts. These alliances not only promote knowledge exchange but also elevate India's stature as a leading hub for medical technology innovation.
Ultimately, our collective efforts are aimed at building Brand India as a synonymous with excellence, innovation, and reliability in the medtech sector. By showcasing our capabilities on the global stage, promoting Indian innovations, and highlighting our commitment to quality and affordability, we aim to position India as the preferred partner for medical technology solutions worldwide.
India stands at the cusp of a transformative journey towards becoming the global capital of medtech. With unwavering commitment, collaborative spirit, and visionary leadership, we are poised to unlock new frontiers in healthcare innovation, driving economic growth, and improving healthcare outcomes for millions around the world. Together, let us forge ahead with determination and optimism, as we shape a future where India leads the way in revolutionising healthcare through cutting-edge medtech solutions.
Anup Kumar Ramachandran,Business Head-Ultrasound,GE HealthCare South Asia highlights that today,both,patients,and clinicians value precision and personalised medicine,hence,the demand for specialised skills continues to grow
What does specialisation mean for patients and clinicians? Why do you believe specialisation is a better long-term strategy for the healthcare system?
Merriam Webster defines specialisation as “structural adaptation of a body part to a particular function or of an organism for life in a particular environment”. The definition itself tells us the importance of specialisation in the context of patients and clinicians. The post-COVID era is defined by precision-led treatments where ‘one size fits all’ approach will not benefit patients especially as changing lifestyles, an ageing population and growing awareness among patients is rapidly transforming how healthcare is perceived.
Today, both, patients, and clinicians value precision and personalised medicine, hence, the demand for specialised skills continues to grow.
The impact on healthcare systems
Specialised systems are more adept at identifying cost-effective diagnostic and treatment options as the therapies are more targeted to suit a particular patient’s needs. By precision-led early diagnosis healthcare professionals can prevent the progression of diseases, leading to less intensive and less expensive treatments. This not only benefits patients by improving their health outcomes but also eases the financial burden on healthcare systems. Specialised systems can help clinicians mentor and train others, fostering a culture of excellence and continuous improvement within healthcare institutions. They contribute
GE HealthCare has been at the forefront of integrating artificial intelligence (AI) and automation into ultrasound technology, significantly improving the capabilities and precision of our applications
to the development of standardised protocols and best practices, which can be disseminated across the healthcare system. This leads to a more consistent and highquality patient care experience, enhancing patient satisfaction and trust in the
healthcare system.
Early specialisation also facilitates the accumulation of practical experience over a longer period. This experience is invaluable because it translates into more precise and confident diagnoses. The more familiar a clinician is
with specialised ultrasound technology and its applications, the more adept they become at identifying subtle signs that may indicate underlying health issues in a particular care area or workflow. This proficiency can significantly enhance the quality of patient care, as early and accurate detection is often the key to effective treatment.
Specialised technologies offer more precise and informed interpretations of specific organ images, allowing clinicians to recognise and understand subtle nuances that might be overlooked in a generalist setting. Additionally, specialisation fosters a deeper understanding of the complexities of various medical conditions. For instance, a specialised ultrasound system in musculoskeletal imaging provides in-depth diagnostic information on the anatomy, pathology, and biomechanics of the musculoskeletal system. This level of expertise is essential for accurate diagnosis and effective treatment planning, significantly improving patient outcomes.
Specialisation is an ideal long-term strategy for multiple reasons. While shared service solutions can be costeffective and convenient, they often lack the depth of expertise that comes with specialisation. Employers recognise the value of specialised skills and are often willing to invest in clinicians who have demonstrated a dedication to mastering a specific area. Specialisation can also open doors to advanced roles within the medical field.
Clinicians with specialised systems play a pivotal role in educating and mentoring future generations of healthcare professionals, further enhancing their professional stature and impact. As healthcare increasingly values precision and personalised medicine, the demand for specialised skills continues to grow. They become integral to multidisciplinary teams, collaborating with other specialists to provide comprehensive and patient-centric care.
Specialisation also contributes to more efficient and effective healthcare systems in the long run. In essence, specialisation leads to better patient outcomes, greater healthcare efficiency, and more sustainable medical practices, making it a superior long-term strategy.
Clinicians can leverage cutting-edge technology to achieve higher levels of specialisation, ultimately leading to better diagnostic capabilities and patient care.
Can you elaborate on the role of AI and automation in enhancing ultrasound specialisation at GE HealthCare?
GE HealthCare has been at the forefront of integrating artificial intelligence (AI) and automation into ultrasound technology, significantly improving the capabilities and precision of our applications. Investments in AI-driven advancements are designed to improve diagnostic accuracy, streamline workflows, and provide more detailed and insightful imaging.
For instance, we were the first in the world to introduce groundbreaking technologies such as fetalHQ, which pro-
vides structural heart assessments in fetus, and SonoCNS, an AI-based assessment of the fetal brain. Additionally, our UGAP technology offers non-invasive quantitative liver fat assessments, and AFI provides quantified cardiac strain imaging. These innovations allow clinicians to perform highly specialized and accurate diagnostics with greater ease and efficiency.
In the realm of Point of Care Ultrasound (POCUS), our AI technology in Venue GO enhances rapid and precise assessments, essential for emergency and critical care
settings. The Vscan, the first handheld ultrasound system, exemplifies our commitment to making advanced diagnostic tools accessible and practical for various medical settings. AI and automation also contribute to a more standardised approach to ultrasound imaging, reducing variability and enhancing the reproducibility of results. This consistency is crucial for making informed clinical decisions and improving patient outcomes.
How does GE HealthCare support continuous profes-
sional development for clinicians specialising in ultrasound?
At GE HealthCare, being a market leader in ultrasound in India and across the world, we strongly believe in the benefits of specialisation within the ultrasound modality. Beyond providing the right tools based on clinicians' needs, we continue to make huge investments in innovations around smart automation, AI, and advanced algorithms designed with specialisation at the core. Every year, we conduct various educational and clini-
cal programs nationwide, which are either led by GE HealthCare or in partnership with key clinical societies in India. These initiatives are designed by specialisation to help clinicians optimally use our technology for superior patient outcomes. Moreover, we foster a global community of clinicians, offering platforms for peer-to-peer connections and the exchange of ideas and knowledge. This community enables the crosspollination of best practices and continuous learning, ensuring that clinicians remain at the forefront of ultrasound
technology and its applications.
At GE HealthCare, we are dedicated to supporting clinicians through every stage of their career, from initial training to advanced specialisation, ensuring they have the resources and knowledge necessary to excel in their practice.
Disclaimer: This article is a promotional feature and does not have journalistic/editorial involvement of Express Healthcare. The content is for information purposes only. Readers must consult a registered medical practitioner.
Shobhit Jain,Sr.Manager,Product – Clinical Chemistry & Urinalysis,Sysmex India Pvt Ltd explains about automation in Urinalysis
Urine analysis is comprising of physical, routine and microscopic examination. It is an integral part of clinical laboratories and one of the most performed diagnostic tests. This simple, noninvasive test is potent screening tool for clinicians, which can provide as much as possible information on the status of renal, urological, infection and metabolic function in the body. Apart from routine screening, it may also be helpful in uncovering status of disease that may not be showing significant signs or symptoms.
A lot of vital information can be obtained through urine examination, still its clinical utility is affected to a great extent by limitation of its conventional manual methods including bio-chemical and microscopy. Biochemical analysis is improved with reagent strips, but challenge remained in microscopic part. Other challenges like non standardisation of process, person to person variation, centrifugation and slide preparation needed a whole automated system in place with minimum human involvement and maximise automation.
In last decade there were
paradigm shift in laboratory operations and now automation is leading the way for Urinalysis testing. Technological advancement in biochemical analysis and microscopic examination in urinalysis has help to set and standardise process.
Automation has changed the way of testing, reporting and documentation of laboratories with improved quality and lowered TAT. Some of the key features of automation in Urinalysis are standardisation, quality control, added clinical values,
Automation has changed the way of testing,reporting and documentation of laboratories with improved quality and lowered TAT.Some of the key features of automation in Urinalysis are standardisation, quality control,added clinical values,data management, accuracy,and reproducibility
data management, accuracy, and reproducibility.
Automation in Urinalysis can be further categorised in Biochemical analysis and Particle analysis (Microscopy). In Biochemical analysis, CMOS sensor has played a great role in identifying strip pad position, optimising detection area, correction of abnormal coloration.
This cutting-edge technology has eliminated all possible errors due to manual process. Similarly, for particle analysis, Fluorescence Flow Cytometry technol-
ogy has great advantage as it can recognise specific and unique properties of different particles by size, labeling DNA, complexity, and specific features, and so determining the particle type. Also, high accuracy of bacteria counts and, accurate differentiation in RBC morphology (Isomorphic and Dysmorphic) is helping in faster diagnosis and better patient care.
Looking at the facts it can be concluded that future of urinalysis lies in automation.
Bry-Air's desiccant dehumidifiers stand out as a reliable choice for maintaining humidity control. These systems safeguard sensitive medical equipment,prevent corrosion,and create a comfortable,hygienic environment conducive to healing
In healthcare settings, maintaining optimal indoor air quality is crucial for protecting patients, staff, and visitors from potential health risks. Hospitals and medical facilities often face challenges with temperature and humidity fluctuations, which can become breeding grounds for harmful bacteria, fungi, and viruses. These conditions further lead to spread of infections and allergies, posing a significant threat to patient safety.
Uncontrolled humidity levels can lead to hazardous microbiological growth and condensation, fostering the proliferation of fungi. Addition-
Uncontrolled humidity levels can lead to hazardous microbiological growth and condensation, fostering the proliferation of fungi
ally, airborne bacteria thrive in environments with fluctuating humidity, which can lead to contamination and health risks. Sensitive medical devices are also at risk, as inaccurate readings due to environmental factors can compromise patient care.
Moreover, vital medical equipment is susceptible to
corrosion in humid conditions, potentially rendering them ineffective or prone to malfunction. This not only affects the functionality of critical devices but also imposes significant financial burdens on healthcare institutions due to repair and replacement costs.
To address these challenges, integrating desiccant
dehumidifiers into air conditioning systems offers an effective solution. Unlike traditional cooling-based methods, desiccant systems provide superior humidity control even at low temperatures, ensuring consistent performance and cost-effectiveness. By targeting the root causes of uncontrolled humidity, such as the ingress of outside air and high moisture content in operating theatres, healthcare facilities can implement tailored solutions for optimal air quality.
Bry-Air's desiccant dehumidifiers stand out as a reliable choice for maintaining humidity control. These systems safeguard sensitive medical
equipment, prevent corrosion, and create a comfortable, hygienic environment conducive to healing. By prioritising indoor air quality management, healthcare facilities can mitigate risks, enhance operational efficiency, and uphold their commitment to patient wellbeing.
Ensuring optimal indoor air quality is a proactive step towards better healthcare outcomes. By investing in advanced humidity control solutions, healthcare institutions can protect their patients and equipment, ultimately fostering a safer and healthier environment for everyone involved.
Designed to meet the highest standards of modern healthcare,HSIL’s modular solutions offer unparalleled benefits for medical facilities
In today’s rapidly evolving healthcare landscape, the need for advanced, flexible, and efficient medical environments has never been greater. Hemant Surgical (HSIL) is at the forefront of this transformation with its cutting-edge Modular OT (Operation Theatre) and ICU (Intensive Care Unit) setups. Designed to meet the highest standards of modern healthcare, HSIL’s modular solutions offer unparalleled benefits for medical facilities.
HSIL’s Modular OT & ICU setups are engineered with stateof-the-art technology to enhance operational efficiency and patient safety. These modular units are crafted to seamlessly integrate with existing infrastructure, providing a versatile solution that adapts to diverse healthcare environments. The advanced design ensures that medical professionals can work in optimal conditions, improving both workflow and patient outcomes.
One of the standout features of HSIL’s modular systems is their ability to be customised to meet the specific needs of each facility. Whether it’s for a small clinic or a large hospital, HSIL offers tailored solutions that address unique requirements. This level of customisation ensures that each OT and ICU setup is perfectly aligned with the facility’s operational goals and space constraints, providing maximum functionality and flexibility.
HSIL’s commitment to quality
is evident in every aspect of their modular setups. Built to the highest standards, these units promise durability and minimal maintenance, ensuring long-term performance and reliability. The robust construction of HSIL’s Modular OT & ICU systems not only meets but exceeds industry standards, contributing to superior patient care and operational excellence.
Conclusion
HSIL's Modular OT & ICU setups represent a significant leap forward in healthcare in-
frastructure. With their advanced design, customisable options, and unwavering quality, HSIL is transforming medical environments to better meet the demands of today’s healthcare professionals. Embrace the future of healthcare with HSIL’s modular solutions and experience the benefits of cutting-edge medical technology tailored to your needs.
For more information, visit HSIL’s Modular OT & ICU Services. :https://hemantsurgical.com/services/modular-operation-theatre-ot-setup
ThenewAlphenixfamilyofinterventionalsystemsdeliver imageswithgreaterclarityandprecision.
Combinedwithindustry-leadingdoseoptimization technologies,enhancedworkflow,andanewsetoffeatures, AlphenixcontinuesCanonMedical’scommitmentto supportingyouandyourmissiontoprovidepatientswith safe,accurateandfastimaging.
https://global.medical.canon/
©CanonMedicalSystemsCorporation2022.Allrightsreserved.
Pleasecontactyourlocalsalesrepresentativetolearnmore.
REGD.WITH RNI NO.MAHENG/2007/22045,POSTAL REGD.NO.MCS/162/2022 – 24,PUBLISHED ON 8TH EVERY MONTH, POSTED ON 14TH,15TH,16TH EVERY MONTH,POSTED AT MUMBAI PATRIKA CHANNEL SORTING OFFICE,MUMBAI – 400001
